A penicillium isolated from the isinglass cover of a photograph of my wife' Helen, on Guam, near the end of the war in 1945, appeared in preliminary experiments to be capable of elaborating a substance active therapeutically against swine influenza virus. Because it possessed this property the culture was submitted to Dr. Charles Thorn and Dr. Kenneth Raper for identification.
acteristic signs of infection, were prepared in 5 per cent suspension in buffered saline (pH 7.3) and divided among a number of screw-capped vials for storage frozen under CO~. until ready for use. Kept in this way, the virus retained an adequate potency for experiment and a single batch sufficed for 3 to 4 months of work. Dilution of the virus suspension to the concentration desired in an individual experiment was made just prior to use and the diluted virus was kept in an ice bath during the time of its administration.
Mice.--In the portion of this work carried on at the Rockefeller Institute, the Rockefeller Institute Swiss strain of mice was used while the Carworth Farms CFW strain of mice was employed in the work at the Merck Institute. Animals weighing from 12 to 16 gm. were used.
Cultivation of Penicillium funiculosum.--P, funiculosum was maintained for study by serial transfer at 2 to 3 week intervals on Sabouraud's agar slants or was stored in a sporulated form on sterilized dirt, sawdust, or wheat grains in cotton-plugged test tubes at refrigerator temperature. The above salts, glucose, and yeast extract are dissolved in 1000 cc. distilled H~O.
The fluid medium in which P. funiculosum elaborates a substance possessing therapeutic activity for swine influenza and SK virus infections has undergone numerous modifications during the course of the work, but the formula which appears most regularly to be satisfactory has the composition shown in Table I . The medium is distributed in either 45 cc. amounts in 125 cc. Erlenmeyer flasks or 120 cc. amounts in 32 oz. Blake bottles and autoclaved. It has a pH of between 5.5 and 6.5 and requires no adjustment.
Preparation of the A ntiviral Substance.--In preparing the antiviral substance, flasks of the medium were inoculated either with a piece of the surface growth of P. funiculosum from a Sabouraud's agar slant, or a suspension of the spores from such a slant in distilled water or physiological salt solution. Stationary cultures were incubated for from 6 to 12 days (usually 7 or 8) on a table or shelf in a room whose temperature could be maintained at ±26°C., and were usually not disturbed between the time of inoculation and harvest. The shake cultures were incubated for from 48 to 72 hours in the same room on a mechanical shaking machine. Stationary cultures fur~shed a good yield of antiviral substance much more regularly than those incubated on a shaking machine. After they had grown for 7 or 8 d~ys they had ordinarily a heavy surface pellicle ranging in color from greenish yellow to red, and considerable mycelium was present in the fluid portion of the culture beneath the pelllcle. The broth of such cultures frequently had an orange or red tinge. In cultures incubated while shaken, there was, of course, no surface pellicle and instead they usually consisted, after 48 hours, of a viscous mass of pale yellow to gray mycelium in balls or loose clumps.
In harvesting, the fluid portions of either stationary or shake cultures were filtered through gauze, using suction or pressure to facilitate filtration, in order to remove floating mycelium. If sterile preparations were desired, the broths were filtered further through Seitz pads.
EXPERIMENTS VCITH SWINE INFLUENZA VIRUS INFECTIONS OF MICE
Tests of mold preparations for therapeutic activity in mice infected with swine influenza virus were conducted in the following manner:--White mice in groups of from 6 to 12 animals per cage were infected with swine influenza virus as described above. Animals that were to serve as controls received 0.3 or 0.5 cc. of uninoculated culture broth intraperitoneally either 2 or 3 times in the first 24 hours after infection. If 3 injections were given, the time intervals after infection were usually 1, 3, and 24 hours, while if only 2 treatments were administered the injection at I hour after infection was omitted. In occasional experiments 1 injection of broth was given several hours prior to infection with virus. Mice in which various mold preparations were to be tested received them in the same amounts, by the same route, and on the same injection schedule as the controls.
Mice dying during the first 48 hours after infection were eliminated from consideration in the experimental results. Such toxic deaths from f~nicu~osum culture fluids were quite rare.
Mice dying later were autopsied to determine whether death had resulted from influenza virus infection. 12 days was selected as the period of observation, since it had been our experience that mice which lived this long were very likely to survlve indefinitely. All mice still alive on the 12th day were killed, autopsied, and examined for influenzal lesions. For purposes of scoring the result they were recorded as having succumbed on the 12th day.
The experimental results were scored by totalling the days of death of all mice in the group and dividing this total by the number of mice in the group to obtain the survival average in days for each group. A perfect score under this method of tabulation was, therefore, 12.
Results of Swine Influenza Virus Experiments
Two typical experiments in which both favorable and unfavorable therapeutic results seemed to have been obtained with broth cultures prepared from colony isolates are given in Tables II and III. In the experiments recorded in Table II the broths harvested from 8 of the colony isolates from a single seeding of P. funiculosum (A-80 to A-88) failed to exert any therapeutic effect against swine influenza virus infections in white mice, and all 10 mice in each group succumbed typically. The broths from the remaining subcultures of the same seeding of P. funiculosum, on the other hand, appeared to exert a favorable therapeutic effect and saved all or a portion of the treated mice. On the 12th day after infection, when this experiment was terminated, part of the groups of surviving mice were autopsied and examined for lesions, and part were tested for immunity to swine influenza by infection with a large dose of virus intmnasally. Roughly 75 per cent of the mice autopsied on the 12th day showed residual influenzal lesions in their lungs and about the same per cent of those tested for immunity survived the challenge infection. It was apparent from these results that treatment had been adequate to avert infection completely in about one-fourth of the surviving animals while in the remaining three-fourths, though it had saved their lives, it had not pre-vented the development of immunity or sufficient infection to cause minimal lung lesions. The experiments outlined in Table III, conducted about 1 year later than  those given in Table II , record less striking therapeutic effects. The crude broths of 3 of the cultures (I-59-61) exerted little or no beneficial influence. However, when these broths were concentrated 2 times by evaporation to half their original volume, their therapeutic effectiveness appeared improved. In like manner, a pooled preparation of 5 therapeutically active broths improved in therapeutic efficacy on similar concentration. These findings indicate that the antiviral substance elaborated by P. funiculosum is capable of concentration by appropriate procedures.
Comment on Swine Influenza Virus Experiments
The findings that have been outlined represent some of the best but also some of the worst therapeutic results obtained in the treatment of swine influenza virus infections in mice during the course of the first 2 years of our work Cultures of individual colonies isolated from a single plate seeding of P. funi~uJosum. § 7 mice in each treatment group.
with P. fun~culosum. Over 2,000 culture isolates of the mold were tested for activity against swine influenza virus during that time, and of these about half gave either completely negative or very unimpressive results. The remaining half gave results which ranged from the prolongation of life of the treated animals to the actual saving of a part or the majority of them. No reason for the inconstancy of the results is apparent and no explanation for the periodic variations and fluctuations in therapeutic potency of the different preparations can now be given.
Consideration of the findings over the period of 6 years during which work has been in progress indicates that cultures grown during the first 2 years were uniformly considerably more active in favorably influencing the outcome of experimental swine influenza virus infections in mice than those prepared dur-ing the last 4 years. The suggestion is obvious that our culture of P. funiculosum has lost some therapeutic property which it originally possessed and which accounted for its favorable effect on mice inoculated with swine influenza virus.
The mold has been subjected to numerous procedures and manipulations in an attempt to return it to its original state, but nothing tried has enabled the culture to regain its therapeutic effect for swine influenza virus infections of mice.
EXPERIMENTS WITH COLUMBIA SK ]ENCEPHALOMYELITIS VIRUS INFECTIONS OF MICE
Partly because our culture of P. funiculosum appeared to have largely lost its capacity to elaborate the antiviral substance active against swine influenza virus, and partly to learn whether it still possessed activity against a virus other than this, experiments with the Columbia SK encephalomyelitis virus were initiated during the 4th year of our study. By this time our culture of P. funiculosum no longer produced the substance that during the first 2 years had been found to be active against swine influenza virus infections. The work with the SK virus was thus begun with a culture of P. funiculosum that, to judge from our findings, had changed from one which in 1946 and 1947 had been quite active in elaborating a substance that was therapeutically active against murine swine influenza to one which in 1949 had lost this activity. During the course of our work we had modified our methods of growing P.
funiculosum in the attempted production of the antiviral substance, though these changes did not appear to be responsible for the loss of activity of the culture because reversion to the initial culture methods failed also to yield preparations that were active against swine influenza virus infections. At the time that work with SK virus was begun, and throughout the remainder of our work, the following method of growing the mold for production of antiviral substance was adopted.
Preparation of Antiviral Substance Active against SK Virus.--In the present and subsequent experiments only stationary cultures of P. funiculosum grown in 32 oz. Blake bottles containing 120 co. of the medium described earlier were employed. The bottles were laid on their flat sides, slightly tilted to prevent wetting of the cotton plugs by the medium. This gave a large area for surface growth. Incubation was at -¢-26°C. for 10 days. Spores of P. funiculosum stored on dry grains of sterile wheat were used as inocuhim, transferring 1 or 2 grains of spore-dusted wheat to each bottle of medium or shaking such wheat with broth in an approximate proportion of 1 grain of wheat to each 2 cc. of broth and using 1 cc. of the resulting spore suspension as inoculum for the Blake bottle cultures.
In harvesting, after 10 days' incubation, the fluid portions of the culture were filtered through sterile gauze-faced milk filter pads in a Buchner funnel with suction. In early experiments reported in this paper the fluid thus obtained was used to treat the infected mice. Later, when it was subsequently found that the pericles possessed much more antiviral activity than did the fluid portions of the cultures the process of harvesting was further modified. The fluid portions of the 10 day old cultures were filtered through gauze as before, while the moist fleshy pericles remained on the gauze pad in the funnel. Mter being sucked free of adherent fluid, the pellicles were transferred to a Waring hiendo~ and ground in this for 3 to 4 minutes, 5 to 10 cc. of the culture fluid being added for each pellicle ground. The resulting gruel-like suspension was then centrifuged at 4-2000 R.p.~r. for 20 minutes. The supernatant, which was rich in antiviral activity, was decanted and saved for use in treating infected mice. It was designated as the "supernatant of the pelllcle suspension" and will be referred to subsequently in this work as the "SPS."
Experimental
Tests of mold preparations for therapeutic activity in mice infected with Columbia SK encephalomyelitis virus were conducted in the following manner.
White mice in groups of 6 animals per cage were infected by injection with the selected dilution of SK virus either intraperitoneally or subcutaneously. The intraperitoneal route was used for only some of the early experiments. In most of those reported in the present paper the subcutaneous route has been employed as routine to avoid any possible in vitro effect of the antiviral substance administered intraperitoneally. Animals that were to serve as controls were either left untreated or received 0.5 cc. amounts of sterile fluid medium intraperitoneally 3 and 24 hours after infection. Mice in which various mold preparations were to be tested for antiviral activity received these by the same routes and on the same injection schedule as the controls received the sterile medium.
Mice dying during the first 48 hours after infection were not included in the experimental results but were classed toxic deaths. Mice dying from the 3rd day onward were considered to have succumbed to SK virus infections. 10 days was selected as the period of observation in these experiments since it has been our experience that mice which lived this long are likely to survive indefinitely.
Since judgment of the therapeutic efficacy of the various mold preparations tested was based on a comparison between the survival times of the control and of the treated mice, it was important that the time of death of individual mice be accurately recorded. Groups of infected mice were checked for dead animals twice daily, and for statistical purposes the deaths were recorded in 24 hour periods, those of the afternoon reading with those of the following morning. Mice that survived 10 days were scored as having succumbed on the 10th day.
In selecting an appropriate method of evaluation it was found that the distribution of survivals in terms of log days more closely approached a normal distribution than did the distribution of survivals in terms of days themselves (3) . Accordingly, the number of deaths occurring in each group for each day was multiplied by the logarithm of the numerical day of the experiment and at the termination of the experiment the products were totalled for each treated or control group of mice to obtain the total log days survived. Division of the total log days by the number of mice in a particular group gave the mean log days of survival for the group, and the antilog of this value was the average survival time in days for the group. A comparison of the survival times in days of groups of treated animals, with the survival time of untreated control animals, was achieved by dividing the values for the treated groups by the corresponding value for the control group. The quotient of this division is a value that enables one to judge the therapeutic efficacy of a substance under test, and throughout the present paper this will be referred to as the survival index (SI). The minimum significant survival indexes have been calculated for us by Dr. W. I-I. Ott to be 1.31 when single groups of 6 mice were used in testing each substance. When more than single groups of 6 mice were employed, the minimum significant values were 1.21 for two groups, 1.17 for three groups, 1.14 for four groups, and 1.13 for five groups. We have not exceeded 30 mice (5 cages of 6 animals) per treated or control group in the present experiments and most of our work has been done using 6, 12, or 18 animals per group. * Tested in groups of 6 mice. These preparations were from cultures of the mold grown during the 4th year of our work.
RESULTS
In Table IV , results are recorded of a group of experiments in which mice, infected with either Columbia SK encephalomyelitis virus or swine influenza virus, were treated with corresponding samples of fluid from stationary cultures of various colony isolates of our strain of P. funiculosum.
The individual mold preparations included in Table IV were administered intraperitoneally in 0.5 cc. amounts to groups of 6 mice 3 and 24 hours after either intranasal inoculation with swine influenza virus or intraperitoneal inoculation with SK encephalomyelitis virus. Of 10 control groups of mice for each virus, all 60 of those infected with SK virus died within the 10 day period of observation, while 58 of the 60 swine influenza controls also succumbed. It is evident from this that the tests for therapeutic efficacy were conducted against almost certainly fatal doses of virus. Of the 28 treated groups of mice, 11 of the 168 animals infected with swine influenza virus survived, while 43 of the 168 infected with SK virus lived. From consideration of the survival indexes recorded in the table, it seems likely that, with the possible exception of samples AL 43 and AL 78, the preparations exerted little if any therapeutic effect against swine influenza virus infections. Against SK encephalomyelitis virus infections, on the other hand, well over half of the preparations had a significant therapeutic effect and a few appeared to be quite highly active.
These results strongly suggest that the substance from P. funiculosum found earlier to be therapeutically active against swine influenza virus may not be the same as that found active against SK virus.
A large amount of work has been conducted in an attempt to obtain higher yields of the antiviral substance from stationary broth cultures of P. funiculosum. The time and temperature of incubation have been varied, attempted selection of colonies for activity has been tried, the constituents of the media have been varied, and numerous other technical variations have been instituted, but in no instance have we come upon any procedure that appears regularly and constantly to increase the yield of antiviml substance in the fluid portion of the cultures. In fact, we were unsuccessful in outlining any procedure that would even insure obtaining good activity from every harvest of culture fluid. It was while attempting to increase our yields that we decided to explore the possibility that the antiviral activity might reside in the solid cellular components of the pellicles.
Antiviral Activity Extractable from the Pdlicles
The peUicles of P. funiculosum grown in Blake bottles in stationary culture are thick, fleshy, spongy, and quite saturated with fluid.
In the experiments in which they were to be tested for the presence of antiviral substance, they were sucked fairly free of adherent fluid on a gauze milk pad in a Buchner funnel and then homogenized in a Waring blendor with approximately equal volumes of various solvents in the hope that one of the solvents would extract the antiviral substance from the bruised cellular components of the pellicles. Ethanol, methanol, acetone, chloroform, physiologic saline buffered at pH 7.3, and culture broth itself were used as the extracting solvents. After homogenizing, the pellicle-solvent mixture was centrifuged to separate the solvent. This was collected by pipette. The saline and culture broth extracfives were tested for activity without further treatment. The other solvents used were evaporated to dryness, and the residues taken up by triturafion in a 2 per cent solution of methocel 1 in distilled water. They were made up in this suspending medium to approximately the same volume as the saline and culture broth preparations. The various preparations were administered intraperitoneally in 0.5 cc. amounts to groups of 6 mice 3 and 24 hours after intraperitoneai inoculation with SK encephalomyelitis virus. The results obtained are given in Table V. With two possible exceptions, none of the organic solvent extractives of the pellicles exerted a favorable therapeutic effect against the SK virus infections to judge by the low survival indexes obtained. The two exceptions, ethanol extract of peUicles of culture 80 and chloroform extract of culture 86, gave survival indexes that bordered on significance. The sahne and broth extracts of the various culture pellicles, on the other hand, all showed some evidence of therapeutic activity and several were quite active to judge by the high survival in-dexes obtained. There appeared to be some advantage in the use of culture broth over buffered saline. It seemed apparent from this experiment that considerable antiviral activity resided in the cellular components of stationary cultures of P. funiculosum and that this activity was extractable with aqueous solvents but not with the organic solvents tried. The solubility of the antiviral substance in water and its apparent insolubility in acetone, as evidenced by the findings in this experiment, have been utilized as a first step in the isolation of the active principle and will be discussed later.
Comparison of the Anti~iral Activity of the Fluid Portions and the Pellicles of Stationary Cultures of P. funiculosum
With the finding, outlined in Table V , that extracts possessing antiviral activity could be obtained from the pellicles of stationary cultures of P. funiculosum by extraction with either buffered saline or culture broth, the suggestion was immediately apparent that the pellicles, which in earlier work had been discarded, might be a more potent and regular source of active material than the fluid portions of the cultures. To test this possibility, the fluid portions and the pellicle extracts of a number of groups of cultures (colony isolates) were tested in parallel for therapeutic activity.
The pellicle extracts were prepared as outlined earlier by homogenizing the pellicles in a Waring blendor and adding 5 to 10 cc. of culture fluid for each pellicle during the blending process. The pellicle extracts (SPS) were thus in reality merely culture fluids containing antiviral substance' liberated from the fragmented cellular constituents of the pellicles. Pools of from 40 to 100 Blake bottle cultures were used in obtaining each sample of either pellicle extract or culture fluid tested. Use of such large numbers of individual cultures in obtaining each sample served the double purpose of decreasing the likelihood of marked variation due to extremely active or inactive individual cultures and of furnishing larger amounts of material for chemical work.
The various culture fluid and pellicle extract preparations were administered intraperitoneally in 0.5 cc. amounts to groups of 12 or more mice 3 and 24 hours after subcutaneous inoculation with SK encephalomyelitis virus. The results obtained are recorded as survival indexes in Table VL As shown in Table VI , the survival indexes given by 29 of the 30 pellicle extracts were higher than the indexes for the corresponding culture fluids. In the exceptional case, culture BC 70, the fluid portion of the culture for some reason was unusually rich in antiviral substance and gave a survival index of 1.64 which equalled that for the pellicle extract. 22 of the 30 culture fluids exerted a significant therapeutic effect against the SK virus infections, while all the pellicle extracts were significantly active. The average survival index for the 30 fluids was 1.27, while for the 30 pellicle extracts it was 1.53. Since at the dosage of virus employed the control animals lived for an average of just under 5 days, these survival indexes meant a prolongation of life of almost 1.5 days in the case of the fluids and of something over 2.5 days in the case of the pellicle extracts--an advantage of slightly over 1 day for the pellicle extracts. Table VI and from numerous others that have been conducted, that much more antiviral activity resided in or remained in intimate association with the cellular constituents of stationary cultures of P. funiculosum than was present in the culture fluid itself. As a consequence of this observation we abandoned our former practice of discard-ing the pellicles in favor of the broth portion of the cultures and began using the peUicles as our source of antiviral substance. Because of the usual presence of a certain amount of antiviral activity in the fluid portions of the cultures, these fluids, instead of water or saline, were used as the solvent in extracting antiviral substance from the fragmented cellular constituents of the pellicles. Preference for culture fluid as extracting solvent was made purely on the basis of using one which already contained at least a small amount of the desired antiviral substance.
Precipitation of the Antiviral Substance with Acetone
With the finding that fairly active amounts of antiviral substance could be regularly extracted from the fragmented cellular components of the pellicles of stationary cultures of P. funiculosum by culture fluid or other aqueous solvents, it appeared that we were ready to attempt chemical isolation and purification of the substance. The findings recorded in Table V, indicating that no active substance could be extracted from the pellicles by treatment with acetone, suggested the use of this as a first step for precipitation of active material from the aqueous solvent.
In a series of preliminary experiments it was found that the addition of 1 volume of chilled acetone to 1 volume of the chilled pellicle extract (SPS) yielded a copious gummy, sticky precipitate containing all or almost all of the antiviral activity. Trials of other proportions of acetone and SPS indicated that equal volumes represented the approximate optimum for precipitation of activity. Because of its sticky, gummy character and also because some of it remained in fine suspension which made filtration through paper difficult, the precipitate was collected by centrifugation at about 2000 1LP.M. for 30 minutes. The supernatant was decanted and discarded and the brown, amorphous, gummy precipitate was scraped from the bottom and sides of the centrifuge bottles with a spatula, using small amounts of distilled water. The material was readily though very slowly soluble in water and all of the precipitate could be finally gotten back into solution by triturating it thoroughly under small amounts of water with a spatula. In dissolving large amounts of the acetone precipitate, homogenization of it with water in a Waring blendor greatly hastened the process. It has been our practice to take the precipitate up in a volume of water equal either to the initial volume of SPS or some fraction of that, usually one-half, for most of our tests. Because the resulting aqueous solution of the acetone precipitate is quite viscous, a concentration to less than one-fourth or one-fifth of the initial SPS volume is impractical owing to the extreme viscosity of the resulting more concentrated preparations.
The results of some tests comparing the therapeutic activity of the redissolved acetone precipitate with that of the original SPS are given in Table VII. It is evident, from the results presented in Table VII , that much or most of the antiviral activity contained in the crude pellicle extracts (SPS) was precipitated by a concentration of 50 per cent acetone. The method employed in assaying the therapeutic activity of the various preparations was too crude to permit the placing of much significance on small differences in the survival indexes shown by different preparations being tested. Also, as will be pointed out later when the matter of dosage response comes up for consideration, the ad-ministration of larger amounts of antiviral substance above a certain level fails to improve the therapeutic result achieved. Many of the tests recorded in Table VII were conducted at a dosage level that lay within this "plateau" region of diminishing response. The gummy, amorphous precipitate obtained by the treatment of SPS with acetone is undoubtedly a mixture whose exact 
* Tested in groups of 12 mice. On basis of volume d original SPS (2 X means that the acetone precipitate was taken up in a volume of water equal to one-half that of the SPS from which the precipitate was derived).
content of anfiviml substance is not known and may be quite small. The process, however, provides a crude means of separating the active material from some of the other constituents of the SPS without appreciable loss of its activity. In order to designate this active substance in terms less cumbersome and more specific than "antiviral substance or material," it will be referred to hereafter as helenine. This name is selected partly because it is non-descriptive and non-committal as to the nature of a substance about whose mode of action and structure we are still ignorant, partly because it is, so far as I am aware, not preempted, but largely out of recognition of the good taste shown by the mold producing the substance in locating on the picture of my wife, Helen, at the time of its isolation.
Dosage Response to A cetone-Pr~ip4tate, d Helenine
As indicated in the preceding section, the therapeutic efficacy of helenine is somewhat peculiar in that a dose level exists above which increasing the amount administered does not improve the therapeutic result. Below this dose level there is a gradual falling off in therapeutic efficacy with diminishing doses of the material. This therapeutic plateau effect is illustrated by the composite experiment summarized in Table VIII . In this experiment acetone precipitation of the SPS of culture BC 56-59 yielded 5.5 mg. of precipitate per cc. while similar treatment of the SPS of culture BC 63 yielded 1.43 mg. per cc. Administration of the precipitate BC 56-59 in total dosages ranging from 1.37 to 11 mg. exerted a good therapeutic effect in the treated mice, and the size of dose within this range seemed to make but little difference in the eventual outcome. Decreasing the dose from 1.37 to 0.55 rag. resulted in some slight falling off of the therapeutic efficacy of the preparation. The acetone precipitate from culture BC 63 at a total dose of 5.72 mg. gave a survival index that was roughly comparable with that achieved by the material from culture BC 56-59. However, progressive quartering of this dose resulted in a falling off in therapeutic efficacy until at a level of 0.09 rag. it was completely without therapeutic effect. No explanation is as yet evident for the plateau effect or why, beyond a certain point, increasing the dose does not increase the therapeutic effect.
The Influence of Time of Administration of Helenine on Its Therapeutic Effect upon SK Encephalomyelitis Virus
Preliminary experiments dealing with the comparative therapeutic effectiveness of 1 treatment dose 3 hours after infection, as compared with divided doses 3 and 24 hours after infection, indicated that, if the single dose was large enough to fall within the plateau zone of maximum effect, then repeating it 24 hours later did not usually increase the therapeutic effect materially. If, however, the initial dose at 3 hours yielded results below the plateau zone of maximum effect, then repeating it 24 hours later usually did improve the therapeutic result as judged by the survival index. Since most of our work was with materials whose therapeutic effectiveness was unknown, we treated our in- fected animals, as routine, 3 and 24 hours after infection to insure a maximum effect, despite the fact that, with a great many preparations, the 24 hour treatment dose was found to be superfluous from the standpoint of improving the therapeutic end result.
In experiments set up to determine how long after infection helenine would still exert a therapeutic effect, only a single treatment dose was administered at various set intervals before or after infection. The experiment recorded in Table IX is typical of several that have been conducted and in it the mice were given a single treatment with a known active acetoneprecipitated SPS (a preparation from culture BC 56-59 whose titration is shojvn in Table  VIII) . 24 mice were treated intraperitoneally in each group at various intervals before or after injection subcutaneously with a dose of SK encephalomyelitis virus adequate to kill all 24 untreated control mice. The results are shown in Table IX. As shown by the experiment outlined in Table IX , a single dose of helenine given either 3 hours before or 3 hours after infection exerted a good therapeutic effect against an SK virus infection and there was only slight falling off in therapeutic effect when treatment was delayed 6 to 12 hours after infection. In other experiments in which groups of mice have received treatment, beginning at hourly intervals after infection, there has appeared to be little variation in therapeutic effectiveness for at least 10 hours. In the present experiment, as well as in others that have been carried out, delay of treatment for 18 hours results in a definite lessening of therapeutic effectiveness of helenine, and when given after 24 hours the survival index that can be achieved is still lower. Treatment delayed until the onset of definite signs of illness in the infected mice is completely without favorable effect. 
Role of Size of Infecting Dose of Virus on the Therapeutic Effect Achieved by Treatment with Helenine
In the experiments described in the present paper we have endeavored to use an infecting dose of SK virus that is between 10 and 1000 times that which will kill all or almost all the untreated control mice. Ordinarily, with this dose of virus the control groups will succumb in between 4.5 and 5.5 days, while animals treated with good preparations of helenine will survive long enough to give averages of from 7.5 to 8.5 days for the treated groups. In order to learn whether the apparent therapeutic effectiveness of a preparation might be modified by variation in the initial infecting dose of virus, several experiments have been carried out, and one is recorded in Table X.
In the experiment shown in Table X , 5 groups of 60 mice each were infected subcutaneously with 0.5 co. doses of SK virus, diminishing by progressive increments. One-half of the mice in each group were injected intraperitoneally with sterile broth 3 and 24 hours after infection and were designated as controls. The other half were treated intraperitoneally with an acetone precipitate of SPSBC 194 3 and 24 hours after infection receiving a total of 24.4 rag. of the acetone precipitate.
As can be seen from the results presented, helenine exerted a favorable therapeutic effect in all 5 groups of mice infected with various doses of SK virus.
Delaying Effect of ttelenine on Invasion of the Brains of Infected Mice by SK Virus
Although in a number of trials we have obtained no clear cut evidence to indicate a direct in vitro action of helenine on SK virus, some of our evidence <1 X 10 II the 3rd and 4th days after infection. The brains of mice that had been treated with helenine, on the other hand, did not contain detectable virus on the 2nd day and were sometimes even free from it on the 3rd day. By the 4th day after infection virus was ordinarily present in their brains though in unusually low titre. The findings of a typical experiment are recorded in Table XI .
In this experiment 12 infected untreated control mice and a similar number of animals treated in the usual manner with helenine were sacrificed at intervals of 2, 3, or 4 days after subcutaneous infection. Their brains were removed aseptically, ground in a mortar, and suspended in buffered saline to make a 10 per cent suspension by wet brain weight. This initial suspension was further diluted by progressive steps of 10 in buffered saline and the series of dilutions were administered intraperitoneally to 4 or 6 mice in 0.5 cc. dosage. The titration end-point of infectivity for each brain was selected as the greatest dilution of infected brain which killed, with typical manifestations, all the mice in its group. While this end-point possibly represents a less accurate method of titration than one utilizing the so called 50 per cent end-point, it is believed to be adequate for the present purpose of determining a difference in the virus content of the brains of treated and untreated mice.
Of the brain samples in which 0.5 cc. of a 10 per cent suspension intraperitoneally failed to kill the test mice in the titration (<1 X 10-1), the samples from control mouse 5 and from treated mice 1, 2, 3, 4, 5, 6, and 12 are believed to have been completely free of virus because none of the test mice died and all appeared normal at the end of the 10 day period of observation. On the other hand, the brain of control mouse 1 also recorded as fiterlng <1 X 10 -1 probably contained a small amount of virus since i of the 4 animals injected with that dilution died showing typical signs of SK virus infection.
The brains of the control mice killed on the 3rd or 4th day after infection contained an amount of virus such that 0.5 cc. of a 1 X 10 -4 or b dilution represented the regularly fatal titration end-point. The brains of the treated mice, on the other hand, that contained any detectable virus on the 3rd or 4th day after infection had titres such that 0.5 ec. of a 1 X 10-~ or ~ dilution was required regularly to kill the test mice.
The evidence presented in Table XI indicates that helenine had a delaying action on the neuroinvasiveness of SK virus and may sometimes also have materially slowed its rate of multiplication in the central nervous system. From the findings presented it would appear that treatment had delayed invasion of the brain for from 24 to 48 hours and that, on the 3rd or 4th day after infection, the fitre of virus in the brains of those treated animals that were by now infected was in the neighborhood of about 1 per cent of that in the brains of corresponding untreated control animals.
That the virustatic effect of helenine is not one that prevails right up to the fatal termination of an SK virus infection of mice is indicated by the findings in the experiment recorded in Table XII. In this experiment the brains of 4 untreated control mice dying on the 4th, 5th, or 6th day, and of 9 treated mice dying on from the 5th to the 8th days after infection were harvested soon after death. They were titrated for their virus content in the manner already outlined for the experiment recorded in Table XI . The findings indicated that the amount of SK virus in the brains of mice at the time of death was approximately the same whether or not the animals had been treated with helenine. The effect of helenine would therefore appear to be merely one of delaying or postponing the build-up in virus to its lethal level in the central nervous system. 
Additive Therapeutic Effect of Helenine and Specific Antiviral Serum
Further in support of the above view are experiments in which an additive therapeutic effect of helenine and specific virus-neutralizing serum was observed. The virus-neutralizing serum was obtained from swine recovered from intracerebral infection with SK virus. One such experiment is presented in Table XIII .
In this experiment 4 groups of mice were infected subcutaneously in the usual manner with SK virus. 1 group was then injected intraperitoneally 3 and 24 hours later with helenine, another group was given a single intraperitoneal injection of swine anti-SK virus serum 48 hours after infection, a 3rd group was given the combined treatment of the first 2 groups (helenine 3 and 24 hours and anti-SK virus serum 48 hours after infection), while the 4th group served as controls and were injected intraperitoneally with sterile broth 3 and 24 hours after infection.
It was found that anti-SK virus serum given 48 hours after infection exerted no sparing effect despite the fact that, from other experiments, it was known that such serum, given 3 or 6 hours after infection, was completely protective against the lethal effects of SK virus. Helenine, on the other hand, exerted a moderate therapeutic effect on the group of infected mice to which it was administered, as evidenced by a survival index of 1.38 for the group. However, a still better therapeutic result was achieved in the group of mice treated with both helenine and anti-SK virus serum. Here the survival index was 1.66 and half of the mice were actually saved. It is believed that results such as these fall in line with the findings outlined in Table VIII and can best be explained on the basis of an inhibition of virus multiplication or invasion of the central nervous system for 48 to 72 hours by helenine, with a consequent favorable result from virus-neutralizing serum given late during this period of virustasis. The action of the helenine in this experiment is visualized as that of a virustatic agent which prolongs the period during which specific virus-neutralizing serum can exert its virucidal activity.
RECAPITULATION AND DISCUSSION
The evidence obtained in this study indicates that a substance, which we have chosen to call helenine, produced by _P. funiculosum, and particularly plentiful in the cellular elements of stationary cultures of this mold, is capable of exerting a marked modifying effect upon the course of infection with Columbia SK encephalomyelitis virus in mice. A substance produced by this same mold culture during the first 2 years after its original isolation and therapeutically active against infection with swine influenza virus in mice is believed to differ from helenine. The original antiviral substance was present in the fluid portions of stationary cultures of P. funiculosum and was highly active against the swine influenza virus. Unfortunately during the time that this substance was available for work we did not conduct studies designed to characterize it for later comparison with other antiviral] substances that the mold might produce. As has been pointed out, our mold culture, as work with it progressed, gradually became more irregular in its production of the anti-influenza virus substance until finally it lost almost completely its capacity to produce it.
The production by P. funiculosum of helenine, active against SK infections of mice, was not looked for or observed until the 4th year of our work, after the culture had apparently largely lost its capacity to produce the anti-influenza virus substance. Hence there has been no opportunity to compare helenine with the antiviml substance that first attracted our attention. That helenine and the initial antiviml substance are qualitatively quite different is indicated by the results with culture fluids, shown in Table IV of the present paper. Many of the preparations presented in this table were quite high in helenine activity when tested against SK virus, but completely devoid of therapeutic effect on swine influenza virus infections. In other experiments, SPS or acetone precipitates of SPS that were highly effective in treating SK virus infections, were completely without effect when used against swine influenza virus infections. A conclusion that seems warranted from the results of numerous tests in which preparations were therapeutically active against SK virus but devoid of effect on swine influenza virus infection is that, whatever the substance initially produced by P. funiculosum, it was not the one to which we refer in this and subsequent papers as helenine. On the other hand, the production of helenine by the mold has not diminished as time has elapsed and, so far as can be told, our culture is as active today in producing the substance as it was when the activity was first observed.
The finding of greater helenine activity in association with the cellular elements of the pellicles than in the culture fluids themselves probably indicates that helenine is largely an intracellular material diffusing into the surrounding medium only irregularly and usually in small amount. It appears to be liberated in quantity only when the cellular components of the pellicles are bruised, fractured, and fragmented by mechanical means. Once liberated from the broken cells it is soluble in water or the surrounding aqueous medium. As shown in this study, it can be precipitated, probably completely, from aqueous solution by organic solvents that are freely soluble in water. We have used acetone largely as the precipitant although either methyl or ethyl alcohol are satisfactory. Unfortunately, from the standpoint of purification or isolation of helenine, precipitation with acetone is not discriminatively selective for it, and other substances come down in the precipitate. There is no way of knowing, from the work carried out thus far, just what proportion of a given acetone precipitate is compr/sed of helenine but it may be quite small. Certainly there is frequently no direct correlation between the amount of acetone-precipitable material present in a crude SPS and its helenine content as judged by therapeutic activity against SK virus.
The quantitative determination of the helenine content of various preparations is handicapped by the plateau effect regularly observed in titrations of helenine activity. Furthermore, the failure of infected animals to respond more favorably to multiple injections of helenine than to single doses when the dose falls within the plateau zone of maximum effect is not adapted to work of a quantitative character. That a dosage response to helenine can be demon-strated is dearly shown in the experiment outlined in Table VIII , and many others like it that have been conducted, but the range in which difference~ can be observed is at the very low dosage levels. The disappointing state of affairs is that, while a helenine dosage effect or response can be shown by decreasing the amount administered below what appears to be a certain optimal level, a material improvement in therapeutic response cannot be elicited by increasing the dose above this level or by increasing the number of times the substance is administered. The case of helenine constitutes a refutation of a rather fixed therapeutic belief that if a little treatment is good a lot of treatment should be better, and the limiting factor with helenine in this instance is not toxicity resulting from the large dose. Rather the limiting factor of helenine therapeutic effect on SK virus infections in mice would seem in some way to be associated with the mechanism by which helenine exercises its antiviral action, a factor which will be more completely discussed in a later paragraph.
The time at which treatment with helenine is begun is an important factor in achieving a favorable therapeutic result in infected mice. There is little if any advantage to beginning treatment before infection. However, delay in beginning treatment beyond 6 to 10 hours after infection results in progressive diminution in the effectiveness of treatment judged on the basis of survival indexes. Delay of treatment for 18 hours results in a definite lowering of therapeutic effectiveness and at 24 hours the survival index that can be achieved is even lower though still statistically significant. Helenine exerts no favorable therapeutic effect if its administration is delayed until the infected mice show actual signs of illness.
If the dose of SK virus used to infect mice is massive, helenine is without effect in modifying the course or outcome of the infection. The most clear cut therapeutic results are obtained against from 10 to 1000 surely fatal doses of virus and the maximum therapeutic effect is achieved at a level of infection that kills untreated mice in an average of about 5 days.
From the facts discussed thus far it is quite apparent that helenine would have no practical value in treating naturally occurring outbreaks of virus diseases resembling the experimental SK virus infections in mice. In order to achieve a favorable therapeutic result, considerable jockeying of experimental conditions is required, and it seems doubtful that these specialized conditions would be met under any conceivable set of natural circumstances. The fact should however be borne in mind that the SK virus, once it has elicited signs in mice, regularly proceeds to a fatal termination and it is conceivable that the experimental test of therapeutic efficacy is more severe than would have to be met under natural conditions of disease and with viral infections less regularly fatal in their outcome. This possibility would have to be taken into consideration before categorically deciding, on the basis of results with SK virus alone, that helenine has no practical application in virus therapensis.
As was mentioned earlier in this discussion, the limiting factor of the helenine therapeutic effect on SK virus infections in mice appears in some way to be associated with the mechanism by which it exercises its antiviral action. While the exact mechanism is not known, some of the experimental work here presented, especially that outlined in Tables XI, XII, and XIII, suggests what it may be. The experiments represented in the first of these tables indicate quite clearly that treatment of infected mice with helenine delays the entrance of virus into the brain for from 24 to 48 hours. They further indicate that on the 3rd or 4th day after infection the titre of virus in the brains of those treated mice that were by then infected was only about 1 per cent of that in the brains of corresponding untreated animals. Two possible explanations of these findings are apparent. One of these is that helenine causes an inhibition, or interruption, of multiplication of the virus, with a consequent slowing down of the whole process of infection and spread to the central nervous system. The other is that helenine in some way interferes temporarily with the neuroinvasiveness of the virus. That the effect of helenine on the virus, whatever it may be, is not one that prevails right up to the fatal termination of the SK virus infection is indicated by the findings in the experiment presented in Table XII . In this experiment, the findings indicate that at the time of death there is no essential difference in the amount of SK virus in the brains of mice, whether or not they had been treated with helenine. The effect of helenine would, therefore, appear to be one to delay the build-up in virus to its lethal level in the central nervous system. Further in support of this view is the experiment outlined in Table  XIII , in which an additive therapeutic effect of helenine and specific virusneutralizing serum was observed. In this experiment specific antiviral serum given 48 hours after infection exerted a life-saving effect on mice that had been treated with helenine but was completely without effect on untreated mice. The action of the helenine under such circumstances is visualized as that of a virustatic substance prolonging the period during which specific virus-neutralizing serum could exert its virucidal activity. All of the information brought to light in this study of the effect of helenine on SK virus infections indicates its action to be that of a substance acting either by inhibition of multiplication of the virus or by interference temporarily with its neuroinvasiveness. Similar experiments with Semliki Forest virus to be reported in an accompanying paper (4) have yielded findings which make possible further elucidation of the possible mechanism of the action of helenine in favorably influencing viral infections. These findings will be discussed in connection with the study of Semliki Forest virus.
SUMMARy
A culture of P. funiculosum isolated on Guam proved capable of elaborating a substance which exerted a favorable therapeutic effect against swine influenza virus infections in white mice. The culture was extremely variable and irregular in its production of the antiviral substance, and during maintenance in the laboratory for several years gradually lost this property. Efforts to restore it were unsuccessful.
Subsequently it was found that the mold elaborated a substance, now designated helenine, which is therapeutically effective against Columbia SK encephalomyelitis virus infections in mice. Helenine appears to differ from the substance earlier procured from the mold, which was active against swine influenza virus infections in mice. It is frequently present in greater or lesser amount in the fluid portions of stationary cultures of P. funiculosum but is more regularly obtained and in larger amount, from the cellular components of the peUicles. When liberated from these latter by mechanical bruising and fracturing, it goes into solution in the culture fluids. It is precipitable from aqueous solution by 50 per cent acetone.
Infected mice injected with helenine in amounts less than the amount which produces a maximal therapeutic effect exhibit a dosage response. Increasing the dose above the optimum fails to increase the therapeutic effect.
Helenine exerts its maximum effect when given within the first 10 hours after viral infection but its influence is apparent even when treatment is delayed for up to 24 hours. It is not effective against massive amounts of virus and gives the best therapeutic results when used in the treatment of animals infected with from 10 to 1000 fatal doses of virus. Treatment of infected mice with helenine delays the entrance of virus into their brains for from 24 to 48 hours.
The mechanism by which helenine exerts its therapeutic effect against SK virus is not known but the findings presented suggest either that it muses an inhibition or interruption of multiplication of the virus, slowing down the whole process of infection and spread to the central nervous system, or that in some way it interferes temporarily with the neuroinvasiveness of the virus.
BIBLIOGRAPHY

